Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 490INDUSTRY 216NIH 17NETWORK 13OTHER_GOV 10UNKNOWN 2FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Prostatic Neoplasms 17Rare Diseases 3Neoplasms 3Neoplasm Metastasis 3Leukemia 3Recurrence 2Lymphoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Genetic Diseases, Inborn 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Squamous Cell 2Adenocarcinoma Of Esophagus 2Turcot syndrome 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Respiratory Aspiration 1Radiation Pneumonitis 1Prostate Cancer Diagnosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Non-Muscle Invasive Bladder Neoplasms 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neuroma, Acoustic 1Neurologic Manifestations 1Neurofibromatosis 2 1Neurofibromatoses 1

Interventions

Oxaliplatin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × FED × Recurrence × Clear all
NCT00557206 2013-11-05

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

Minneapolis Veterans Affairs Medical Center

Phase 2 Terminated
35 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

NCT00018538 2009-01-21

Calcifidol Therapy in Men With Cancer

VA Office of Research and Development

Phase 2 Completed
Genitourinary

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡